This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other congenital malformations of integument
Q17_OTHER_CONGEN_MALFO_INTEG
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
33 |
4. Check minimum number of eventsNone |
33 |
5. Include endpointsNone |
33 |
6. Filter based on genotype QC (FinnGen only) |
33 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q8
- Name in latin
- Aliae malformationes congenitae integumenti communis
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of integument
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 511 | 262 | 249 |
| Only index persons | 338 | 168 | 170 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | - | 3.79 | 2.43 |
| Only index persons | 7.85 | 9.18 | 6.53 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 33 | 17 | 16 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 25.84 | 27.78 | 23.78 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
11
42
3.43
2.48
3.7
5.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
23
4.24
2.46
1.8
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
8
24
4.06
2.36
1.1
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
19
105
2.91
2.27
6.1
8.0
umol/l
10.9
10.5
0.10
19
98
(3018677) aPTT in Platelet poor plasma by Coagulation assay
8
26
3.72
2.18
2.3
5.0
s
30.2
29.0
—
8
26
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
24
168
2.57
1.75
8.0
6.6
u/l
97.5
82.5
0.52
24
154
(40768797) Stomach Pathology biopsy report
6
20
3.43
1.66
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
12
60
2.57
1.63
3.1
4.9
ng/l
21.0
16.2
—
6
32
(3044889) 12 lead EKG panel
22
151
2.37
1.46
4.2
2.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
14
79
2.34
1.46
1.5
1.5
g/l
2.0
2.0
—
7
40
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
25
2.70
1.31
5.8
11.1
mmol/l
24.4
25.5
—
6
25
(42870588) Differential panel, method unspecified - Blood
14
85
2.12
1.19
6.1
8.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
32
2.50
1.16
1.7
2.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
5
22
2.49
1.07
1.6
4.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
37
2.13
1.01
1.3
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
26
215
1.98
0.90
12.5
8.4
ml/min/173m2
99.5
95.4
0.39
20
169
(3026008) Bacteria identified in Urine by Culture
9
52
2.00
0.86
2.0
2.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
33
2.00
0.83
1.5
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
13
86
1.84
0.82
4.2
5.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
9
56
1.83
0.81
2.2
2.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
7
39
2.00
0.79
2.1
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
25
2.17
0.76
2.2
1.2
—
—
—
0
0
(3015736) pH of Urine
14
98
1.74
0.72
2.6
2.9
—
—
—
0
0
(3026782) Osmolality of Urine
7
43
1.79
0.72
2.6
1.9
mosm/kgh2o
604.9
576.5
—
7
36
(3003694) ABO and Rh group [Type] in Blood
11
72
1.79
0.70
1.5
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
12
82
1.73
0.66
4.3
5.0
u/l
33.8
30.8
0.20
12
76
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
20
0.00
0.62
0.0
1.0
—
3.7
—
0
15
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
19
0.00
0.62
0.0
1.7
—
293.8
—
0
13
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
22
0.00
0.62
0.0
1.0
—
4.4
—
0
14
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
7
47
1.62
0.52
4.4
2.3
u/l
129.7
159.5
—
7
47
(3013512) EKG study
7
47
1.62
0.52
1.6
2.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
10
70
1.61
0.49
4.2
7.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
32
1.66
0.44
2.0
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
9
68
1.44
0.43
2.6
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9
68
1.44
0.43
5.1
3.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
5
35
1.50
0.41
2.8
5.5
ng/l
316.0
1084.5
—
5
29
(3037522) Nuclear Ab [Titer] in Serum
5
36
1.46
0.40
2.0
1.8
—
640.0
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
36
1.46
0.40
2.2
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
63
1.35
0.31
1.6
1.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
11
0.00
0.22
0.0
9.5
—
1.0
—
0
11
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
11
0.00
0.22
0.0
3.5
—
55.7
—
0
11
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
11
0.00
0.22
0.0
9.5
—
0.8
—
0
11
(3002523) Influenza virus A Ag [Presence] in Specimen
0
11
0.00
0.22
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
11
0.00
0.22
0.0
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
0
10
0.00
0.22
0.0
3.9
—
25.6
—
0
10
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
10
0.00
0.22
0.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
14
0.00
0.20
0.0
9.4
—
131.1
—
0
14
(3001019) Free T4 and TSH panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
11
92
1.29
0.19
3.0
3.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
8
66
1.28
0.19
3.3
2.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
8
68
1.23
0.18
3.5
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
6
76
0.74
0.18
3.0
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
9
77
1.23
0.18
3.0
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
18
164
1.21
0.14
3.2
3.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
28
270
1.24
0.09
10.6
13.0
%
39.9
40.0
0.02
19
230
(3011397) Hemoglobin [Presence] in Urine by Test strip
7
64
1.12
0.09
2.9
3.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
7
67
1.06
0.08
3.4
3.2
mmol/l
2.3
2.4
—
7
60
(1761868) Lipid panel - Serum or Plasma
10
93
1.11
0.02
1.8
2.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
6
0.00
0.00
0.0
111.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
50
1.00
0.00
1.2
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
0
6
0.00
0.00
0.0
81.2
—
0.9
—
0
6
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
43.8
—
0
6
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
0
6
0.00
0.00
0.0
81.2
—
1.6
—
0
6
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
25
245
1.08
0.00
3.2
3.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
26.3
—
1.0
—
0
7
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
2.1
—
0
5
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
95
0.93
0.00
2.9
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
3.0
—
7.0
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_INTEG and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_INTEG.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_INTEG – Other congenital malformations of integument
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data